Needle-free influenza vaccine on the horizon
Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...
CNET2m
Still Need a Flu Vaccine? Now May Be a Good Time to Get One
Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...
Armed robbery in Revesby5h
Needle-free Influenza Vaccine On Horizon
Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...
GlobalData on MSN23h
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...
biopharma-reporter1d
FDA removes clinical hold on Novavax’s COVID-19-influenza combo vaccine
The FDA had put a clinical hold on Novavax’s COVID-19-influenza combo vaccine after an adverse event in a patient. The U.S.
earth1d
How did the COVID pandemic influence the seasonal flu?
The seasonal flu places a significant burden on healthcare systems globally, leading to over five million hospitalizations ...
emjreviews.com23h
FDA Lifts Hold on COVID-Flu Combo Vaccine Trial
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Daily1d
USFDA removes clinical hold on Novavax COVID Influenza combination, stand alone Influenza Phase 3 trial
Gaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, has announced that ...
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
Business Insider13h
Novavax Advances Vaccine Strategy Amid Financial Shifts
In its recent third-quarter 2024 earnings report, Novavax highlighted significant advancements in its vaccine portfolio, including the removal of a clinical hold by the U.S. FDA on its ...